The global Biosimulation Market was valued at USD 4.1 billion in 2025 and is projected to reach USD 14.8 billion by 2033, expanding at a CAGR of 17.3% from 2026 to 2033. North America dominated the market with a 44.2% revenue share in 2025, while Asia Pacific is expected to record the fastest growth during the forecast period. Increasing drug resistance in...